Reversal of multidrug resistance in cancer cells by Rhizoma Alismatis extract
Research output: Journal Publications and Reviews › RGC 21 - Publication in refereed journal › peer-review
Author(s)
Detail(s)
Original language | English |
---|---|
Pages (from-to) | 160-165 |
Journal / Publication | Phytomedicine |
Volume | 14 |
Issue number | 2-3 |
Publication status | Published - 19 Feb 2007 |
Link(s)
Abstract
Prolonged chemotherapy may lead to the selective proliferation of multidrug resistant (MDR) cancer cells. In MDR HepG2-DR and K562-DR cells that over-expressed P-glycoprotein (Pgp), the extract of the rhizomes of Alisma orientalis (Sam) Juzep. showed a synergistic growth inhibitory effect with cancer drugs that are Pgp substrates including actinomycin D, puromycin, paclitaxel, vinblastine and doxorubicin. At the same toxicity levels the herbal extract was more effective than verapamil, a standard Pgp inhibitor, in enhancing cellular doxorubicin accumulation and preventing the efflux of rhodamin-123 from the MDR cells. The extract restored the effect of vinblastine on the induction of G2/M arrest in MDR cells. Our data suggest that A. orientalis may contain components that are effective inhibitors of Pgp. © 2006 Elsevier GmbH. All rights reserved.
Research Area(s)
- HepG2-DR cells, K562-DR cells, Multidrug resistance, P-glycoprotein, Rhizoma Alismatis
Citation Format(s)
Reversal of multidrug resistance in cancer cells by Rhizoma Alismatis extract. / Fong, W. F.; Wang, C.; Zhu, G. Y. et al.
In: Phytomedicine, Vol. 14, No. 2-3, 19.02.2007, p. 160-165.
In: Phytomedicine, Vol. 14, No. 2-3, 19.02.2007, p. 160-165.
Research output: Journal Publications and Reviews › RGC 21 - Publication in refereed journal › peer-review